Opportunity Information: Apply for PAR 18 367
The NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required), funding opportunity number PAR-18-367, is a National Institutes of Health grant mechanism designed to help promising postdoctoral researchers make the jump into independent, tenure-track academic careers. The core goal is to support the transition from a postdoctoral fellowship (or an equivalent early research position) into an assistant professor role (or a comparable independent position), with the expectation that the awardee will build a sustainable, independent research program in the biomedical arena. A defining feature of this opportunity is its explicit focus on strengthening diversity in the research workforce: the National Cancer Institute (NCI), through the Diversity Training Branch (DTB) in the Center to Reduce Cancer Health Disparities (CRCHD), invites applications specifically from scientists who are from backgrounds that are nationally underrepresented in biomedical, behavioral, clinical, and/or social sciences. The program’s broader context is aligned with NCI’s cancer health disparities mission, reinforcing the idea that expanding who conducts cancer research can also expand what questions get asked and how effectively research addresses diverse populations.
This K22 is structured to provide protected time for research by supplying salary support and research funds for a period of three years, starting when the candidate begins a tenure-track faculty appointment. In practical terms, the award is meant to create breathing room during the high-pressure early faculty period, so the investigator can focus on launching a research program, generating publishable findings, and building the foundation needed for future independent NIH funding. As indicated in the title, the award is “Clinical Trial Required,” meaning the supported research is expected to involve a clinical trial component under NIH definitions, rather than being strictly preclinical or observational. Applicants should therefore be prepared to propose a project that fits NIH’s clinical trial policy framework and to plan for the regulatory, ethical, and operational responsibilities that come with clinical research.
Eligibility in the listing is broad on the institutional side, spanning many U.S.-based organization types that can serve as applicant institutions. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions in that category); for-profit organizations other than small businesses; small businesses; and other miscellaneous eligible entities. The announcement also highlights a variety of mission-relevant institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. Even with this wide range of eligible U.S. entities, the opportunity is clear that foreign participation is not permitted in the form of applicant organizations or components: non-U.S. (foreign) institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed.
Administratively, the opportunity is categorized as a discretionary grant within the education and health activity area, under CFDA number 93.398, and is administered by the National Institutes of Health (with NCI as the sponsoring institute for this program). The source record lists an original closing date of 2021-05-07 and a creation date of 2017-11-20, indicating this is an established program announcement rather than a one-time competition. While the excerpt does not specify an award ceiling or the number of expected awards, the intent is clear: this mechanism is meant to be a career acceleration tool for underrepresented postdoctoral scientists, providing a time-limited but strategically crucial period of protected support to establish independence, build a research portfolio, and position the investigator for long-term success as an independent cancer researcher.Apply for PAR 18 367
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
- This funding opportunity was created on 2017-11-20.
- Applicants must submit their applications by 2021-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) - PAR-18-367
What is PAR-18-367?
PAR-18-367 is the NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required), an NIH career development mechanism intended to help promising postdoctoral researchers transition into independent, tenure-track academic careers while strengthening diversity in the research workforce.
Which NIH institute sponsors this opportunity?
The opportunity is administered by the National Institutes of Health (NIH) and sponsored by the National Cancer Institute (NCI).
What is the main goal of this K22 award?
The main goal is to support the transition from a postdoctoral fellowship (or equivalent early research position) into an assistant professor role (or a comparable independent position), with the expectation that the awardee will establish a sustainable, independent biomedical research program.
How does this award promote diversity?
NCI, through the Diversity Training Branch (DTB) within the Center to Reduce Cancer Health Disparities (CRCHD), invites applications specifically from scientists from backgrounds that are nationally underrepresented in biomedical, behavioral, clinical, and/or social sciences.
How is this program connected to cancer health disparities?
The program aligns with NCI's cancer health disparities mission, reflecting the idea that expanding who conducts cancer research can broaden the questions asked and improve how research addresses diverse populations.
When does the three-year support period begin?
The three-year period starts when the candidate begins a tenure-track faculty appointment.
How long is the supported period under this award?
The award provides support for three years.
What types of support does the K22 provide?
The K22 provides protected time for research by supplying salary support and research funds during the early faculty period, helping the investigator launch a research program and build a foundation for future independent NIH funding.
What does "Clinical Trial Required" mean for this opportunity?
"Clinical Trial Required" means the supported research is expected to include a clinical trial component under NIH definitions, rather than being strictly preclinical or purely observational.
What should applicants be prepared to do because a clinical trial is required?
Applicants should be prepared to propose a project that fits NIH's clinical trial policy framework and to plan for the regulatory, ethical, and operational responsibilities that come with clinical research.
Who is this award designed to help?
This award is designed for promising postdoctoral researchers (or those in equivalent early research positions) who are ready to make the jump into independent, tenure-track academic roles and who are from nationally underrepresented backgrounds in relevant scientific fields.
Is the award meant to provide "protected time" during early faculty years?
Yes. A central purpose is to create breathing room during the high-pressure early faculty period so the awardee can focus on launching an independent research program, producing publishable findings, and preparing for future NIH funding.
What kinds of institutions are eligible to apply as the applicant organization?
Eligible applicant institutions include many U.S.-based entity types, including state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions in that category); for-profit organizations other than small businesses; small businesses; and other miscellaneous eligible entities.
Are minority-serving institutions specifically mentioned as relevant or eligible?
Yes. The announcement highlights institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), among others.
Are community-based, faith-based, or regional organizations mentioned?
Yes. The listing mentions faith-based or community-based organizations and regional organizations as part of the broad set of eligible U.S. entities described.
Are U.S. territories or possessions included in the eligible entity types?
Yes. The announcement notes U.S. territories or possessions among the referenced eligible entities.
Is foreign participation allowed?
No. Foreign participation is not permitted in the form of applicant organizations or components.
Can a non-U.S. (foreign) institution apply?
No. Non-U.S. (foreign) institutions are not eligible to apply.
Can a U.S. organization include a non-U.S. component?
No. Non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed under NIH definitions?
No. Foreign components, as defined by the NIH Grants Policy Statement, are not allowed.
How is this opportunity categorized administratively?
It is categorized as a discretionary grant within the education and health activity area.
What is the CFDA number listed for this program?
The listing provides CFDA number 93.398.
What is the funding opportunity number?
The funding opportunity number is PAR-18-367.
Is this described as a one-time competition or an established announcement?
Based on the creation date and the way it is presented, it is described as an established program announcement rather than a one-time competition.
What dates are provided in the listing?
The source record lists a creation date of 2017-11-20 and an original closing date of 2021-05-07.
Does the excerpt state an award ceiling or the number of expected awards?
No. The excerpt does not specify an award ceiling or the number of expected awards.
What outcomes is the award trying to enable during the three-year period?
The award is intended to help the investigator generate publishable findings, launch and stabilize an independent research program, and build the foundation needed to pursue future independent NIH funding.
What career stage is emphasized for the transition supported by this award?
The transition emphasized is from postdoctoral-level research (or an equivalent early research position) into an assistant professor or comparable independent role.
Is the focus limited to a specific research area?
The description frames the work as biomedical research and places it in the context of NCI priorities, including cancer research and the broader mission related to cancer health disparities.
Browse more opportunities from the same category: Education, Health
Next opportunity: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional)
Previous opportunity: Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 367
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 367) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional) Apply for PAR 18 218 Funding Number: PAR 18 218 Agency: National Institutes of Health Category: Education, Health Funding Amount: $3,000,000 |
| Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 18 219 Funding Number: PAR 18 219 Agency: National Institutes of Health Category: Education, Health Funding Amount: $5,000,000 |
| Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) Apply for PA 18 370 Funding Number: PA 18 370 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19 Clinical Trial Optional) Apply for PAR 18 231 Funding Number: PAR 18 231 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| A Family-Centered Self-Management of Chronic Conditions (R01 Clinical Trial Optional) Apply for PA 18 383 Funding Number: PA 18 383 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Population Health Interventions: Integrating Individual and Group Level Evidence (R21)- Clinical Trials Not Allowed Apply for PA 18 406 Funding Number: PA 18 406 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional Apply for PAR 18 378 Funding Number: PAR 18 378 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R21 Clinical Trial Optional) Apply for PA 18 389 Funding Number: PA 18 389 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01 Clinical Trial Optional) Apply for PA 18 386 Funding Number: PA 18 386 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Population Health Interventions: Integrating Individual and Group Level Evidence (R01) - Clinical Trial Optional Apply for PA 18 385 Funding Number: PA 18 385 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Population Health Interventions: Integrating Individual and Group Level Evidence (R01) Clinical Trials Not Allowed Apply for PA 18 356 Funding Number: PA 18 356 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional Apply for PAR 18 352 Funding Number: PAR 18 352 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Family-Centered Self-Management of Chronic Conditions (R21 Clinical Trial Optional) Apply for PA 18 380 Funding Number: PA 18 380 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Clinical Trial Required) Apply for PA 18 393 Funding Number: PA 18 393 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Population Health Interventions: Integrating Individual and Group Level Evidence (R21) - Clinical Trials Optional Apply for PA 18 407 Funding Number: PA 18 407 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21 Clinical Trial Optional) Apply for PA 18 354 Funding Number: PA 18 354 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01 Clinical Trial Optional) Apply for PA 18 355 Funding Number: PA 18 355 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional) Apply for PAR 18 023 Funding Number: PAR 18 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional) Apply for PAR 18 022 Funding Number: PAR 18 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Apply for PAR 18 246 Funding Number: PAR 18 246 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 367", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
